{"id":120515,"date":"2021-08-27T13:13:14","date_gmt":"2021-08-27T13:13:14","guid":{"rendered":"https:\/\/fin2me.com\/?p=120515"},"modified":"2021-08-27T13:13:14","modified_gmt":"2021-08-27T13:13:14","slug":"cathie-woods-ark-invest-buys-over-170000-shares-of-pfizer","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/cathie-woods-ark-invest-buys-over-170000-shares-of-pfizer\/","title":{"rendered":"Cathie Wood’s ARK Invest Buys Over 170,000 Shares of Pfizer"},"content":{"rendered":"
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 170,000 shares of Pfizer Inc. (NYSE: PFE) on Thursday, as the price of this fund was down over 1% in the day\u2019s session. It is still up a fair amount in the past year.<\/p>\n
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 173,579 shares of Pfizer. At Thursday\u2019s closing price, this would have valued this purchase at roughly $8.2 million. This is only a small fraction of the total holdings. The fund is up 36% over the past 52 weeks.<\/p>\n
Check out all the ARK Invest buys for Thursday:<\/p>\n
Fund<\/th>\n | Ticker<\/th>\n | Name<\/th>\n | Shares<\/th>\n<\/tr>\n<\/thead>\n |
---|---|---|---|
ARKF<\/td>\n | PDD<\/td>\n | PINDUODUO<\/td>\n | 59,300<\/td>\n<\/tr>\n |
ARKF<\/td>\n | COIN<\/td>\n | COINBASE GLOBAL<\/td>\n | 7,054<\/td>\n<\/tr>\n |
ARKG<\/td>\n | RPTX<\/td>\n | REPARE THERAPEUTICS<\/td>\n | 2,468<\/td>\n<\/tr>\n |
ARKG<\/td>\n | QSI<\/td>\n | QUANTUM-SI<\/td>\n | 34,201<\/td>\n<\/tr>\n |
ARKG<\/td>\n | PSNL<\/td>\n | PERSONALIS<\/td>\n | 40,468<\/td>\n<\/tr>\n |
ARKG<\/td>\n | PFE<\/td>\n | PFIZER<\/td>\n | 173,579<\/td>\n<\/tr>\n |
ARKG<\/td>\n | MASS<\/td>\n | 908 DEVICES<\/td>\n | 25,000<\/td>\n<\/tr>\n |
ARKG<\/td>\n | DYNS<\/td>\n | DYNAMICS SPECIAL PURPOSE<\/td>\n | 1,696<\/td>\n<\/tr>\n |
ARKG<\/td>\n | ADPT<\/td>\n | ADAPTIVE BIOTECHNOLOGIES<\/td>\n | 62,252<\/td>\n<\/tr>\n |
ARKG<\/td>\n | BEAM<\/td>\n | BEAM THERAPEUTICS<\/td>\n | 17,033<\/td>\n<\/tr>\n |
ARKG<\/td>\n | CMIIU<\/td>\n | CM LIFE SCIENCES II<\/td>\n | 25,000<\/td>\n<\/tr>\n |
ARKK<\/td>\n | VCYT<\/td>\n | VERACYTE<\/td>\n | 26,653<\/td>\n<\/tr>\n |
ARKK<\/td>\n | NVTA<\/td>\n | INVITAE<\/td>\n | 319,045<\/td>\n<\/tr>\n |
ARKK<\/td>\n | SGFY<\/td>\n | SIGNIFY HEALTH<\/td>\n | 178,955<\/td>\n<\/tr>\n |
ARKK<\/td>\n | FATE<\/td>\n | FATE THERAPEUTICS<\/td>\n | 60,075<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | KTOS<\/td>\n | KRATOS DEFENSE & SECURITY SOLUTIONS<\/td>\n | 201,508<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | KMTUY<\/td>\n | KOMATSU<\/td>\n | 21,700<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | AVAV<\/td>\n | AEROVIRONMENT<\/td>\n | 8,767<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | ACIC<\/td>\n | ATLAS CREST INVESTMENT<\/td>\n | 460,000<\/td>\n<\/tr>\n |
ARKW<\/td>\n | SPLK<\/td>\n | SPLUNK<\/td>\n | 116,466<\/td>\n<\/tr>\n |
ARKW<\/td>\n | LPSN<\/td>\n | LIVEPERSON<\/td>\n | 23,856<\/td>\n<\/tr>\n |
ARKW<\/td>\n | GENI<\/td>\n | GENIUS SPORTS<\/td>\n | 135,457<\/td>\n<\/tr>\n |
ARKX<\/td>\n | PRNT<\/td>\n | 3D PRINTING ETF<\/td>\n | 12,670<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n \nCatherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24\/7 Wall St.<\/em>\n\t\t<\/p>\n |